@article{bb8cea52b8a348aa8c3e3bd32cb9d373,
title = "Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance",
keywords = "Axilla, Humans, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy, Specialization, Surveys and Questionnaires, Axillary staging, Node-positive, Breast cancer, Treatment-response, Axillary lymph node dissection, Neoadjuvant systemic therapy",
author = "Simons, {J M} and Maaskant-Braat, {A J G} and Luiten, {E J T} and Leidenius, {M H} and {van Nijnatten}, {T J A} and Boelens, {P G} and Koppert, {L B} and {van der Pol}, {C C} and {van de Velde}, {C J H} and Audisio, {R A} and Smidt, {M L}",
note = "Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jan,
doi = "10.1016/j.ejso.2019.10.022",
language = "English",
volume = "46",
pages = "218--219",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "1",
}